Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX®
Study Identifier
GMA-CAN-NEU-0336
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
This study will prospectively assess long term heath related quality of life in chronic migraine patients currently being treated with OnabotulinumtoxinA for injection (BOTOX®) as standard of care.
Study Locations
Location
Status
Location
Foothills Medical Centre
Calgary, Alberta, Canada, T2N 2T9
Status
Not applicable
Location
Hys Medical Centre
Edmonton, Alberta, Canada, T5H 4B9
Status
Not applicable
Location
Bayside Medical Centre
Brentwood Bay, British Columbia, Canada, V8M 1P6
Status
Not applicable
Location
Jeff Oyler
Kamloops, British Columbia, Canada, V2C 5T1
Status
Not applicable
Location
Dhawan Medical Corporation Medical Clinic
Vancouver, British Columbia, Canada, V5Z 4E1
Status
Not applicable
Location
May Ong-Lam
Vancouver, British Columbia, Canada, V6Z 2E8
Status
Not applicable
Showing {first} - {last} of {total} Results